(-)-gallocatechin gallate has been researched along with ssya10-001 in 1 studies
| Studies ((-)-gallocatechin gallate) | Trials ((-)-gallocatechin gallate) | Recent Studies (post-2010) ((-)-gallocatechin gallate) | Studies (ssya10-001) | Trials (ssya10-001) | Recent Studies (post-2010) (ssya10-001) |
|---|---|---|---|---|---|
| 19 | 0 | 10 | 13 | 0 | 7 |
| Protein | Taxonomy | (-)-gallocatechin gallate (IC50) | ssya10-001 (IC50) |
|---|---|---|---|
| DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | Homo sapiens (human) | 2.24 | |
| DNA dC->dU-editing enzyme APOBEC-3A isoform a | Homo sapiens (human) | 38.9 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 0.046 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, L; Bassi, ÊJ; Cardoso, SH; da Silva Santos-Júnior, PF; da Silva-Júnior, EF; de Andrade Brandão, J; Silva, LR; Xavier de Araújo-Júnior, J | 1 |
1 review(s) available for (-)-gallocatechin gallate and ssya10-001
| Article | Year |
|---|---|
Druggable targets from coronaviruses for designing new antiviral drugs.
Topics: Animals; Antiviral Agents; Drug Design; Humans; Middle East Respiratory Syndrome Coronavirus; Pandemics; SARS-CoV-2 | 2020 |